Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in IDYA — IDEAYA Biosciences, Inc.

CIK 861177 NEW YORK, NY
Back to IDYA Full portfolio

Position in IDYA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,340,226
-$495,802 QoQ
Shares Held
143,285
-18.2% QoQ
Ownership
0.148%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 286 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in IDYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,443,898,601 across 206 Biotechnology names. IDYA ranks #59 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,086,683 $1,533,248,041
2 REGN
Regeneron Pharmaceuticals, Inc.
 716,560 $446,803,817
3 ALNY
Alnylam Pharmaceuticals, Inc.
 727,848 $219,104,078
4 INCY
Incyte Corp
 1,508,720 $171,028,494
5 RVMD
Revolution Medicines, Inc.
 912,335 $170,862,094
6 INSM
INSMED Inc
 1,335,071 $142,345,265
7 IONS
Ionis Pharmaceuticals Inc
 1,454,672 $115,340,938
8 MRNA
Moderna, Inc.
 1,521,849 $106,575,080

All Filings in IDYA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,340,226 143,285
2026-03-31 $5,836,028 175,151
2025-12-31 $6,019,461 174,124
2025-09-30 $5,481,259 201,443
2025-06-30 $5,731,310 272,660
2025-03-31 $4,965,512 303,145
2024-12-31 $8,308,446 323,286
2024-09-30 $10,089,950 318,496
2024-06-30 $10,964,041 312,277
2024-03-31 $10,159,006 231,518
2023-12-31 $9,752,510 274,101
2023-09-30 $7,295,145 270,391
2022-12-31 $582,748 32,072
2022-09-30 $224,889 15,073
2022-06-30 $139,380 10,100
2022-03-31 $113,019 10,100
2021-12-31 $238,764 10,100